Remimazolam Has Low Oral Bioavailability and No Potential for Misuse in Drug-Facilitated Sexual Assaults, with or Without Alcohol: Results from Two Randomised Clinical Trials

ConclusionThe oral bioavailability of remimazolam is negligible, which —together with its distinct bitter taste—suggests no meaningful potential for misuse in drug-facilitated sexual assaults via oral ingestion, with or without alcohol.Clinical Trial Registration NumbersTrial 1 (NCT04113564) and trial 2 (NCT04113343) both retrospectively registered on 2 October 2019.
Source: Drugs in R&D - Category: Drugs & Pharmacology Source Type: research